Purinostat Mesylate for Injection

Purinostat Mesylate · Chengdu Zenitar Biomedical Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Purinostat Mesylate for Injection, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma [Phase 3]

See pricing